Why the study?
Cardiac myxomas are the most frequent cardiac tumors, and the study aimed to describe their incidence, clinical symptoms, investigation findings, and surgical management.
Surgical resection of cardiac myxomas is safe and effective, providing excellent postoperative outcomes and symptom relief with no short-term recurrences.
Answers are grounded in this paper and cite their sources.
Supports resection for cardiac myxomas with favorable early results; leaves open long-term efficacy in larger cohorts.
Introduction: Cardiac myxomas are the most frequent cardiac tumors. The aim of study is to describe the incidence, clinical symptoms, investigation findings and surgical management of cardiac myxomas. Methods: From July 2015 to July 2017, 15 patients of primary intracardiac myxoma underwent surgical excision at our institute. Their age ranged from 40 years to 65 years with predominance of female patients (73.3%). Surgical resection was done in all the cases via biatrial approach or right atriotomy. Postoperative echocardiogram was done in all patients before discharge. Maximal follow-up of two years and minimum follow-up of 6 months was done after surgery. Results: The tumors presented in a variety of ways, namely, dyspnea (66.7%), chest pain (26.27%) and transient ischemic attack (6.6%), beingthe common modes of presentation. The most common location for the tumor was the left atrium (80%) with the fossa ovalis being the most common (66.7%) site of attachment. No mortality or any significant morbidity was found. On follow-up all patients were in NYHA class 1 and their echocardiography showed good ventricular function with normal pulmonary artery pressure with patch in situ. No recurrence was reported till date.
No takes yet. Share an insight, caveat, or question.
Dhananjay Bansal (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: